• Products
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Trading Platforms
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Trading Platforms
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Share Market Today
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Stockshaala
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Stockshaala
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
​

Krishna Institute of Medical Sciences Ltd's Q3FY25 Quarter Results

Krishna Institute of Medical Sciences Ltd's revenue increased 29.7% YoY
  • 07 Feb 2025
  • Krishna Institute of Medical Sciences Ltd reported a 1.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 29.7%.
  • Its expenses for the quarter were up by 5.7% QoQ and 29.4% YoY.
  • The net profit decreased 23.4% QoQ and increased 20.8% YoY.
  • The earnings per share (EPS) of Krishna Institute of Medical Sciences Ltd stood at 2.2 during Q3FY25.
(₹ crores) Q3FY25 Q2FY25 Q3FY24 QoQ (%) YoY (%)
Total Income
790.20
782.30
609.09
1.0%
29.7%
Total Expenses
655.60
620.10
506.53
5.7%
29.4%
Profit Before Tax
134.60
162.20
102.57
-17.0%
31.2%
Tax
42.10
41.50
25.90
1.4%
62.5%
Profit After Tax
92.50
120.70
76.55
-23.4%
20.8%
Earnings Per Share
2.20
2.70
9.00
-18.5%
-75.6%

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Krishna Institute of Medical Sciences Ltd is a prominent healthcare provider in India, specializing in delivering comprehensive medical services across various specialties. The company operates a network of hospitals that offer a wide range of healthcare services, including tertiary and quaternary care, across multiple medical disciplines. Known for its commitment to quality healthcare, Krishna Institute of Medical Sciences Ltd provides services such as cardiology, neurology, orthopedics, and oncology, among others. Recently, the company has been expanding its reach and enhancing its service offerings to cater to the growing demand for healthcare services in the region. Specific recent developments concerning strategic partnerships, technological advancements, or expansion activities are not available from the data provided.

In the third quarter of fiscal year 2025 (Q3FY25), Krishna Institute of Medical Sciences Ltd reported a total income of ₹790.20 crores. This marks a 1.0% increase from the previous quarter (Q2FY25), where total income was ₹782.30 crores. Compared to the same quarter in the previous year (Q3FY24), there is a significant year-over-year growth of 29.7% from ₹609.09 crores. The consistent increase in revenue highlights the company's ability to sustain growth over different fiscal periods. The rise in total income can be attributed to the increasing demand for healthcare services and potentially expanded service offerings or improved patient intake.

For Q3FY25, Krishna Institute of Medical Sciences Ltd reported a profit before tax of ₹134.60 crores, which reflects a decrease of 17.0% when compared to the previous quarter's ₹162.20 crores. However, on a year-over-year basis, there is a 31.2% increase from ₹102.57 crores in Q3FY24. The tax expense for Q3FY25 amounted to ₹42.10 crores, showing a slight quarter-over-quarter increase of 1.4% from ₹41.50 crores and a 62.5% increase year-over-year from ₹25.90 crores. The profit after tax for Q3FY25 was ₹92.50 crores, down by 23.4% from the previous quarter's ₹120.70 crores but up by 20.8% from ₹76.55 crores in Q3FY24. Despite the quarterly decline in profits, the year-over-year growth indicates an overarching positive trend in profitability.

The earnings per share (EPS) for Krishna Institute of Medical Sciences Ltd in Q3FY25 stood at ₹2.20, which is a decline of 18.5% from ₹2.70 in Q2FY25 and a significant decrease of 75.6% from ₹9.00 in Q3FY24. This decline reflects the decrease in quarterly profits and suggests variations in share performance compared to prior periods. The total expenses in Q3FY25 were ₹655.60 crores, which represents an increase of 5.7% from the previous quarter's ₹620.10 crores and a year-over-year increase of 29.4% from ₹506.53 crores in Q3FY24. The rise in expenses could be associated with operational scaling or increased costs associated with service provision, which have impacted the company's quarterly profitability.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -

​N
​N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]